- Home
- KALV vs CURV Comparison
KALV vs CURV Comparison
Compare KALV & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- CURV
- Stock Information
- Founded
- KALV N/A
- CURV 2001
- Country
- KALV United States
- CURV United States
- Employees
- KALV N/A
- CURV N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- CURV Clothing/Shoe/Accessory Stores
- Sector
- KALV Health Care
- CURV Consumer Discretionary
- Exchange
- KALV Nasdaq
- CURV Nasdaq
- Market Cap
- KALV 418.1M
- CURV 402.0M
- IPO Year
- KALV N/A
- CURV 2021
- Fundamental
- Price
- KALV $8.36
- CURV $4.77
- Analyst Decision
- KALV Strong Buy
- CURV Hold
- Analyst Count
- KALV 6
- CURV 5
- Target Price
- KALV $26.25
- CURV $5.25
- AVG Volume (30 Days)
- KALV 421.6K
- CURV 783.6K
- Earning Date
- KALV 12-31-2024
- CURV 12-03-2024
- Dividend Yield
- KALV N/A
- CURV N/A
- EPS Growth
- KALV N/A
- CURV 29.45
- EPS
- KALV N/A
- CURV 0.14
- Revenue
- KALV N/A
- CURV $1,121,714,000.00
- Revenue This Year
- KALV N/A
- CURV N/A
- Revenue Next Year
- KALV N/A
- CURV $0.80
- P/E Ratio
- KALV N/A
- CURV $33.90
- Revenue Growth
- KALV N/A
- CURV N/A
- 52 Week Low
- KALV $7.98
- CURV $2.18
- 52 Week High
- KALV $16.88
- CURV $9.14
- Technical
- Relative Strength Index (RSI)
- KALV 36.75
- CURV 61.37
- Support Level
- KALV $8.48
- CURV $4.35
- Resistance Level
- KALV $9.30
- CURV $4.31
- Average True Range (ATR)
- KALV 0.65
- CURV 0.36
- MACD
- KALV -0.06
- CURV 0.06
- Stochastic Oscillator
- KALV 17.12
- CURV 94.15
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America targeting 27 to 42-year-old women. It is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of e-Commerce platform and stores.